-
101
Lipoprotein Lipase and PPAR Alpha Gene Polymorphisms, Increased Very-Low-Density Lipoprotein Levels, and Decreased High-Density Lipoprotein Levels as Risk Markers for the Development of Visceral Leishmaniasis by Leishmania infantum
Published 2014-01-01“…In visceral leishmaniasis (VL) endemic areas, a minority of infected individuals progress to disease since most of them develop protective immunity. …”
Get full text
Article -
102
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
Published 2024-04-01“…<h4>Background</h4>Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL endemic areas. …”
Get full text
Article -
103
Missed, but Momentous: A Comprehensive Review of Neglected Tropical Skin Diseases in Southern India and their Global Impact
Published 2025-01-01Subjects: Get full text
Article -
104
The leishmaniases in Kenya: A scoping review.
Published 2023-06-01“…Endemic in over 100 countries, the four types of leishmaniasis-visceral leishmaniasis (VL) (known as kala-azar), cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and post-kala-azar dermal leishmaniasis (PKDL)-put 1.6 billion people at risk. …”
Get full text
Article -
105
Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species
Published 2019-01-01“…Herein, we review the distribution, morbidity, and mortality among male and female leishmaniasis patients. Additionally, we discuss experimental findings and new avenues of research concerning sex-specific responses in cutaneous and visceral leishmaniasis. …”
Get full text
Article -
106
-
107
Inflammatory Nasal Swelling due to Leishmania tropica
Published 2021-01-01“…Since its discovery in the 19th century, cutaneous leishmaniasis has been a major public health problem, especially with the appearance of more and more unusual cases of cutaneous lesions due to this parasite. …”
Get full text
Article -
108
Developments in Diagnosis and Antileishmanial Drugs
Published 2012-01-01“…Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the genus Leishmania. …”
Get full text
Article -
109
Strategies to Overcome Antileishmanial Drugs Unresponsiveness
Published 2014-01-01“…In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. …”
Get full text
Article -
110
Synthesis and evaluation of nitrochromene derivatives as potential antileishmanial therapeutics through biological and computational studies
Published 2025-01-01“…Abstract Leishmaniasis is a parasitic disease caused by protozoan organisms belonging to the Leishmania genus, affecting many individuals worldwide, with the burden surpassing one million cases. …”
Get full text
Article -
111
Bacterial, fungal and parasitic co-infections in leprosy: A scoping review.
Published 2023-05-01“…Rather, co-infections with tuberculosis and leishmaniasis appeared to reduce leprosy reactions.…”
Get full text
Article -
112
Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection
Published 2012-01-01“…Infection is the outcome of a contest between a pathogen and its host. In the disease leishmaniasis, the causative protozoan parasites are harbored inside the macrophages. …”
Get full text
Article -
113
YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
Published 2025-01-01“…Tests performed in clinical isolates indicated that YAT2150 had also strong activity against Plasmodium vivax (IC50 between 4 and 36 nM) and Leishmania infantum (1.27 and 1.11 µM), placing it as a unique compound with perspectives of becoming the first drug to be used against both malaria and leishmaniasis.…”
Get full text
Article -
114
Dyarrheal Syndrome in a Patient Co-Infected with Leishmania infantum and Schistosoma mansoni
Published 2012-01-01“…This case report describes an atypical clinical presentation of visceral leishmaniasis affecting the digestive tract and causing malabsorption syndrome in a patient without recognized immunosuppressive condition. …”
Get full text
Article -
115
-
116
Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease
Published 2016-01-01“…Leishmaniasis is a group of neglected diseases whose clinical manifestations depend on factors from the host and the pathogen. …”
Get full text
Article -
117
A Novel Sesterterpenoid, Petrosaspongin and γ-Lactone Sesterterpenoids with Leishmanicidal Activity from Okinawan Marine Invertebrates
Published 2024-12-01“…Leishmaniasis is a major public health problem, especially affecting vulnerable populations in tropical and subtropical regions. …”
Get full text
Article -
118
Novel Arsenic Nanoparticles Are More Effective and Less Toxic than As (III) to Inhibit Extracellular and Intracellular Proliferation of Leishmania donovani
Published 2014-01-01“…Visceral leishmaniasis, a vector-borne tropical disease that is threatening about 350 million people worldwide, is caused by the protozoan parasite Leishmania donovani. …”
Get full text
Article -
119
Comparing the Trends of Vector-Borne Diseases (VBDs) before and after the COVID-19 Pandemic and Their Spatial Distribution in Southern Iran
Published 2023-01-01“…However, the difference between observed and expected values revealed that the consequences of the COVID-19 pandemic had increased the number of leishmaniasis cases. Conclusion. Tropical regions of Iran, including Fars province, are the favorite destinations for travelers. …”
Get full text
Article -
120
La Leishmaniosis
Published 2007-08-01“…Rey, is the Spanish language version of ENY-738: Leishmaniasis. It describes this disease caused by parasitic protozoans transmitted to humans by sandflies. …”
Get full text
Article